How academia and the pharmaceutical industry can work together: The president's lecture, annual meeting of the American Thoracic Society, San Francisco, California

Annals of the American Thoracic Society

Volumn 10, Issue 1, 2013, Pages 31-38

  Rosenblatt, Michael ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; DRUG RESEARCH; FUNDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL LITERATURE;

ACADEMIC MEDICAL CENTERS; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; INVENTIONS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84878049564     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201209-075PS     Document Type: Article

References (25)

1. The Nobel Prize in Physiology or Medicine 1950. Nobelprize.org [accessed 2012 Jul 19]. Available from: http://www.nobelprize.org/nobel-prizes/medicine/ laureates/1950/
2. Lewis Hastings Sarett. December 22, 1917-November 29, 1999. The National Academies Press (http://www.nap.edu/readingroom/books/biomems/lsarett.htm) 2012 [accessed 2012 Jul 19]. Available from: http://www.nap.edu/readingroom/books/ biomems/lsarett.html.
3. The Nobel Prize in Physiology or Medicine 1952. Nobelprize.org [accessed 2012 Jul 19]. Available from: http://www.nobelprize.org/nobel-prizes/medicine/ laureates/1952/
4. Hart PD. A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s. BMJ 1999;319:572-573.
5. Isaacson W. Steve Jobs. New York, NY: Simon & Schuster; 2011.
6. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;9:203-214.
7. - 2011 Merck Form 10-K. Merck & Co, Inc. 2012 Feb [accessed 2012 Jul 26]. Available from: http://www.merck.com/investors/financials/annual-reports/ home.html
8. Apple Inc. Form 10-K. Apple Inc. 2011 Oct [accessed 2012 Jul 26]. Available from: http://files.shareholder.com/downloads/AAPL/ 1990832756x0xS1193125-11-282113/320193/filing.pdf
9. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, Beck CA, George BP, Moses H III. Funding of US Biomedical Research, 2003-2008. JAMA 2010;303:137-143.
10. Moses H III, Dorsey ER, Matheson DH, Thier SO. Financial anatomy of biomedical research. JAMA 2005;294:1333-1342.
11. Research!America. America Speaks, Poll Data Summary, Volume 5; 2004. Available from: http://www.researchamerica.org/uploads/AmericaSpeaksV5.pdf
12. Jasny BR, Chin G, Chong L, Vignieri S. Again, and again, and again: Data replication and reproducibility. Science 2011;334:1225.
13. Naik G. Scientists' Elusive Goal: Reproducing Study Results. Wall Street Journal 2011 Dec [accessed 2012 Aug 5]. Available from: http://online.wsj.com/ article/SB10001424052970203764804577059841672541590.html.
14. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011;10:712.
15. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012;483:531-533.
16. Reliability of 'new drug target' claims called into question. Nature.com 2011 Sep [accessed 2012 Jul 27]. Available from: http://blogs.nature.com/news/ 2011/09/reliability-of-new-drug-target.html.
17. A new pathway for the regulation and governance of health research. The Academy of Medical Sciences 2012 Jan [accessed 2012 Jul 26]. Available from: http://www.acmedsci.ac.uk/index.php?pid=99&puid=209.
18. Califf RM, Filerman GL, Murray RK, Rosenblatt M. The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation. Institute of Medicine 2012 Apr [accessed 2012 Jul 25]. Available from: http://www.iom.edu/z/ media/Files/Perspectives-Files/2012/Discussion-Papers/Drug%20Forum- Call%20for%20CTE.pdf.
19. Reiss TF, Moss J, Osborne M, Curtis JR, Hill NS. Collaborative science and the American Thoracic Society: cooperation in harmony with conflict of interest. Am J Respir Crit Care Med 2012;185: 347-349.
20. Peabody FW. The care of the patient. JAMA 1927;88:877-882.
21. Pharmaceutical Research and Manufacturers of America. Drug discovery and development: understanding the R&D process [accessed 2012 Jul 26]. Available from: http://www.Inovation.org
22. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2011 update. Circulation 2011;123: e8-e209.
23. Department of Health and Human Services, Centers for Disease Control and Prevention. HIV mortality (through 2008) [accessed 2012 Jul 26]. Available from: http://www.cdc.gov/hiv/topics/surveillance/resources/slides/mortality/index. html
24. Credit Suisse, F-D-C Reports, Inc. and Windhover Information Inc. Adapted with permission from IN VIVO: The Business and Medicine Report. Elsevier; 2009.
25. Munos B. Lessons from 60 years of pharmaceutical innovation. Nature Reviews: Drug Discovery 2008;8:959-968.